No Data
No Data
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Express News | GlycoMimetics Merger-Bound Crescent Appoints Joshua Brumm As CEO
Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics
GLYCOMIMETICS Earnings Preview: Recent $GLYC Insider Trading, Hedge Fund Activity, and More
Cantor Fitzgerald Initiates GlycoMimetics(GLYC.US) With Buy Rating
GlycoMimetics Analyst Ratings